As Axin is a negative regulator of β-catenin/TCF-dependent cell proliferation (Kikuchi, 1999) and carcinogenesis (Barker et al, 2000), loss of Axin expression in oesophageal SCC may lead to tumour progression. Here, AXIN1 is linked to neoplasm.